Fuminori Kanaya Selected Research

echistatin

12/2016	The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.
1/2016	Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fuminori Kanaya Research Topics

Disease

25	Neoplasms (Cancer) 07/2021 - 07/2007
19	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 07/2007
11	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2009
5	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 01/2017
3	Liposarcoma 08/2018 - 01/2018
2	Follicular Dendritic Cell Sarcoma 06/2019 - 05/2016
2	Embolism (Embolus) 01/2017 - 08/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2016 - 10/2014
2	Ischemia 08/2013 - 01/2008
1	Necrosis 07/2021
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Rupture 01/2018
1	Fibrosarcoma 01/2015
1	Rotator Cuff Injuries 07/2011
1	Pain (Aches) 01/2011
1	Hypoxia (Hypoxemia) 01/2008
1	Genetic Translocation (Chromosomal Translocation) 10/2007
1	Opitz trigonocephaly syndrome 10/2007
1	Cicatrix (Scar) 08/2007

Drug/Important Bio-Agent (IBA)

13	Green Fluorescent ProteinsIBA 02/2021 - 01/2013
10	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 05/2016
10	IntegrinsIBA 01/2019 - 04/2013
7	Red Fluorescent ProteinIBA 01/2019 - 04/2013
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
4	CollagenIBA 01/2019 - 08/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2008
3	Temozolomide (Temodar)FDA LinkGeneric 09/2019 - 11/2018
2	pazopanib FDA Link 09/2019 - 08/2018
2	Pharmaceutical PreparationsIBA 06/2019 - 01/2017
2	PlasticsIBA 01/2018 - 08/2014
2	echistatinIBA 12/2016 - 01/2016
2	DisintegrinsIBA 12/2016 - 01/2016
2	ChromatinIBA 08/2016 - 10/2014
1	Cyclin-Dependent Kinase 4IBA 07/2021
1	palbociclibIBA 07/2021
1	Everolimus FDA Link 07/2021
1	TOR Serine-Threonine KinasesIBA 07/2021
1	MTOR InhibitorsIBA 07/2021
1	Fluorouracil (Carac)FDA LinkGeneric 09/2019
1	Sunitinib (Sutent)FDA Link 09/2019
1	L-methionine gamma-lyaseIBA 09/2019
1	eribulin FDA Link 09/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2018
1	TrabectedinIBA 08/2018
1	matrigelIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Peptides (Polypeptides)IBA 12/2016
1	cyclic arginine-glycine-aspartic acid peptideIBA 12/2016
1	veliparibIBA 08/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2016
1	dactolisibIBA 05/2016
1	Carrier Proteins (Binding Protein)IBA 10/2014
1	fucoxanthinolIBA 10/2013
1	fucoxanthinIBA 10/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2013
1	Carotenoids (Carotene)IBA 10/2013
1	Fibronectins (Fibronectin)IBA 08/2013
1	NestinIBA 01/2013
1	CytokinesIBA 01/2013
1	Methylnitronitrosoguanidine (MNNG)IBA 10/2009
1	Bromodeoxyuridine (BrdU)IBA 01/2008
1	Immunoglobulins (Immunoglobulin)IBA 10/2007
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2007
1	Messenger RNA (mRNA)IBA 08/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2007
1	MidkineIBA 07/2007
1	Heparin (Liquaemin)FDA LinkGeneric 07/2007
1	AntibodiesIBA 07/2007

Therapy/Procedure

9	Therapeutics 07/2021 - 07/2007
3	Absorbable Gelatin Sponge 01/2021 - 08/2014
2	Drug Therapy (Chemotherapy) 09/2019 - 11/2018
2	Transplantation 01/2019 - 09/2014
2	Lasers (Laser) 01/2019 - 08/2013
1	Neoadjuvant Therapy 09/2019
1	Sutures (Suture) 01/2018
1	Operative Surgical Procedures 07/2011